Eric J. Evans is an experienced life sciences senior executive. After beginning his career in brand management at Procter & Gamble and in strategy consulting at the Boston Consulting Group, he went on to be Managing Director of Growth Analytics LLC, an international consulting firm specializing in early-stage life sciences technologies. He subsequently served as CEO for several biomedical companies, including Targeted Cell Therapies, Abazyme, Lumos Catheter Systems, Mulleris Therapeutics, Follica Biosciences, Primatope Therapeutics and Pykus Therapeutics. Currently he serves as Executive Chairman of Unison Medicines and is assisting NIH (National Institutes of Health) with their RADx (Rapid Acceleration of Diagnostics) initiative. Mr. Evans holds a master’s degree in finance and public policy from the Wharton School at the University of Pennsylvania, and a bachelor’s degree in nuclear physics from Brown University. He holds an appointment as Senior Fellow at the Harvard Kennedy School.